首页--政治、法律论文--法律论文--法学各部门论文--行政法论文

抵制假药品--以非洲尼日利亚为例

摘要第5-7页
Abstract第7-9页
Introduction第12-23页
    0.1 Background and Purpose of the Study第13-14页
    0.2 Definition of Key Term第14-15页
    0.3 Scope of Problem第15-17页
        0.3.1 Scope of Study第17页
    0.4 LITERATURE REVIEW第17-21页
    0.5 METHODOLOGY第21-22页
    0.6 Theoretical Approach第22-23页
1 A Blueprint of Counterfeit Drug Trade in Nigeria第23-30页
    1.1 The Size and History of Nigeria’s Fake Drug Market第23-25页
    1.2 The Backbones of Pharmaceutical Counterfeiting第25-30页
        1.2.1 Drug Manufacturers第25-26页
        1.2.2 Drug Importers/Wholesalers/Retailers第26页
        1.2.3 Drug Professionals (The Pharmacists)第26-27页
        1.2.4 Informal Drug Sellers第27-28页
        1.2.5 Consumers第28页
        1.2.6 The Controller第28-30页
2 The Routes and Motivating Factors Influencing Drug Trade In Nigeria第30-39页
    2.1 Production and Distribution第30-31页
    2.2 Costs of Medicines第31-32页
    2.3 Reasons for the Increase in Production and Demand Substandard Drugs第32-39页
        2.3.1. Non-professionals in drug business第33-34页
        2.3.2 Drug distribution networks第34-35页
        2.3.3 Poor Implementation of Drug Laws/Inadequate Legislation第35-36页
        2.3.4 Low Literacy Level第36页
        2.3.5. Inefficient Cooperation between Stakeholders第36-37页
        2.3.6 Illegal Drug Importation第37页
        2.3.7 Corruption and Greed第37页
        2.3.8 High Cost of Good Quality Drugs第37-38页
        2.3.9 Demand Exceeding Supply第38-39页
3 Overview some of Prominent illnesses: The Case of HIV/AIDS in Africa第39-57页
    3.1 Major Diseases affecting the Population第40-41页
        3.1.1 Malaria第40页
        3.1.2 Tuberculosis (TB)第40-41页
    3.2 The Case of HIV/AIDS and Fight Against fake Antiretroviral第41-48页
        3.2.1 The Advent of HIV & AIDS in Africa第41-45页
        3.2.2 Social Stigma and despondency第45页
        3.2.3 Government Responses to AIDS第45-47页
        3.2.4 Global response to AIDS in Africa第47-48页
    3.3 Southern Africa and the Fight for Treatment第48-56页
    3.4 Nigeria and the spread of fake Antiretroviral第56-57页
4 Nigeria’s Battle Against Counterfeited Pharmaceuticals第57-73页
    4.1 Functions of Various Units in NAFDAC:第58-60页
    4.2 NAFDAC VS Fake Drugs Within The Legal Market:第60-69页
        4.2.1 Inspection Process as a Check to Drug Faking第60-61页
        4.2.2 Other Interventions for Inspection by NAFDAC第61-62页
        4.2.3 Implementations Of Product Registration第62-63页
        4.2.4 Enforcement Activities as a Check to Drug Faking第63-64页
        4.2.5 Interventions from NAFDAC Enforcement第64-66页
        4.2.6 Public Enlightenment Programs第66页
        4.2.7 Enforcement of NAFDAC Public Enlightenment Programs第66-69页
    4.3 The Pharmaceutical Council of Nigeria Vs Fake Drugs第69页
    4.4 Pharmaceutical Companies第69-70页
    4.5 Drugs Dealers第70页
    4.6 Customs第70-73页
5 Conclusion and Recommendations第73-83页
    5.1 Shortcomings by Institutions In the Fight against Counterfeit drugs第73-75页
    5.2 Proposed Solutions to the Crisis第75-83页
        5.2.1 For the Government/NAFDAC第78-81页
        5.2.2 Manufacturers and Drug dealers第81页
        5.2.3 Pharmacists society of Nigeria (PSN)第81-82页
        5.2.4 Consumers/buyers第82-83页
REFERENCES第83-88页
List of Acronyms第88-90页
Acknowledgements第90-91页
Resume第91-92页

论文共92页,点击 下载论文
上一篇:被征地农民土地权利法律保障制度研究
下一篇:森林生态补偿主体探讨